article Trends in pancreatic cancer literature – findings from Elsevier 9 December 2020 | By Victoria Rees (Drug Target Review) In a new report, Elsevier describes how it used text mining to reveal the top trends in pancreatic cancer research – this article outlines the findings.
news Chemical reactions database updates to improve R&D information exchange 26 February 2020 | By Victoria Rees (Drug Target Review) The newest version of the Unified Data Model (UDM) project has been released, allowing R&D scientists to access information on compound synthesis and testing.
news Researchers highlight link between microbiome and melanoma 4 February 2020 | By Victoria Rees (Drug Target Review) A study of published papers has revealed the importance of research into how the microbiome affects the development of melanoma.
article Developing an algorithm to predict drug-induced liver injury 23 January 2020 | By Victoria Rees (Drug Target Review) A collaboration between Elsevier and the FDA will present an algorithm for the accurate prediction of drug-induced liver injury. Drug Target Review investigates the benefits this toxicology project will bring to the drug discovery industry.
news Elsevier launches The Hive to showcase Pharma/ biotech start-ups 14 July 2017 | By Niamh Marriott (Drug Target Review) Elsevier has announced that applications and nominations for The Hive, its innovation hub for biotech and pharmaceutical startups, are now open.
news Solution to accelerate drug discovery process by DDI analysis 21 June 2017 | By Drug Target Review Elsevier has launched a new solution aimed at accelerating drug discovery through comprehensive prediction and assessment of drug-drug interactions (DDI).
news Elsevier chooses 4 biotech start-up firms for R+D project “The Hive” 21 October 2016 | By Niamh Louise Marriott, Digital Content Producer All four firms will receive training and access to Elsevier's suite of information solutions, to empower their work and help overcome R&D challenges...